|
ErycDrug - Eryc The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, DELAYED REL PELLETS; ORAL
Active Ingredient(s) -
Erythromycin
Strength -
250MG
Applicant -
MAYNE PHARMA USA
New Drug Application (NDA) Number -
050536
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Mayne Pharma Usa Inc
Eryc
Invanz Eq 1gm Base/vial Injectable; Intramuscular, Iv (infusion)
Eryc 250mg Capsule, Delayed Rel Pellets; Oral Hydrogenated Ergot Alkaloids 1mg Tablet; Sublingual Medihaler Ergotamine 0.36mg/inh Aerosol, Metered; Inhalation Ergomar 2mg Tablet; Sublingual Ergostat 2mg Tablet; Sublingual Wigrettes 2mg Tablet; Sublingual Tarceva Eq 100mg Base Tablet; Oral Tarceva Eq 150mg Base Tablet; Oral Tarceva Eq 25mg Base Tablet; Oral NewDrugInformation |